Scott Bussom

The Four-Herb Chinese Medicine PHY906 Reduces Chemotherapy-Induced Gastrointestinal Toxicity

Wing Lam, Scott Bussom, Fulan Guan et al. · Science Translational Medicine · 2010 · 345 citations

PHY906(KD018), an adjuvant based on a 1800-year-old Chinese medicine, enhanced the anti-tumor activity of Sorafenib by changing the tumor microenvironment

Wing Lam, Zaoli Jiang, Fulan Guan et al. · Scientific Reports · 2015 · 109 citations · Full text

Identification of chemicals and their metabolites from PHY906, a Chinese medicine formulation, in the plasma of a patient treated with irinotecan and PHY906 using liquid chromatography/tandem mass spectrometry (LC/MS/MS)

Wei Zhang, Muhammad Wasif Saif, Ginger E. Dutschman et al. · Journal of Chromatography A · 2010 · 81 citations · Full text

Biochemistry, Active Ingredient, Medicine +11

Structure–activity studies of phenanthroindolizidine alkaloids as potential antitumor agents

Wenli Gao, Scott Bussom, Susan P. Grill et al. · Bioorganic & Medicinal Chemistry Letters · 2007 · 80 citations · Full text

Medicinal Chemistry, Biochemistry, Phenanthroindolizidine Alkaloids +8

First-in-human phase II trial of the botanical formulation PHY906 with capecitabine as second-line therapy in patients with advanced pancreatic cancer

Muhammad Wasif Saif, Jia Li, Lynne Lamb et al. · Cancer Chemotherapy and Pharmacology · 2013 · 72 citations

Pancreatic Cancer, Medicine, Botanical Formulation Phy906 +7